(Total Views: 292)
Posted On: 09/27/2022 12:20:51 PM
Post# of 219

$SYN News Article - Synthetic Biologics Announces Positive Outcome of Data and Safety Monitoring Committee (DSMC) Review in Phase 1b/2a Clinical Trial of SYN-004 (ribaxamase) in Allogeneic Hematopoietic Cell Transplant Recipients https://marketwirenews.com/news-releases/synt...99262.html


My Twitter: WhyteStocks